Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001011438-17-000074
Filing Date
2017-02-10
Accepted
2017-02-10 14:21:51
Documents
1
Group Members
AGLAIA BIOMEDICAL VENTURES B.V.AGLAIA ONCOLOGY SEED FUND B.V.KARL ROTHWEILERMARK KRUL

Document Format Files

Seq Description Document Type Size
1 form_sc13g-aglaia.htm SC 13G 129861
  Complete submission text file 0001011438-17-000074.txt   131586
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Subject) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89510 | Film No.: 17592170
SIC: 2834 Pharmaceutical Preparations

Mailing Address PROFESSOR BRONKHORSTLAAN 10 BUILDING 92 BILTHOVEN P7 3723 MB
Business Address PROFESSOR BRONKHORSTLAAN 10 BUILDING 92 BILTHOVEN P7 3723 MB 31302296090
Aglaia Oncology Fund B.V. (Filed by) CIK: 0001676644 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G